Butler, J., Djatche, L. M., Sawhney, B., Chakladar, S., Yang, L., Brady, J. E., & Yang, M. (2020). Clinical and economic Burden of Chronic Heart failure and reduced ejection Fraction following a worsening heart failure event. Advances in Therapy, 37(9), 4015–4032. https://doi.org/10.1007/s12325-020-01456-1
Cook, C. (2013). The annual global economic burden of heart failure. International Journal of Cardiology, 171(3), 368–376. https://doi.org/10.1016/j.ijcard.2013.12.028
Heidenreich, P. A., Fonarow, G. C., Opsha, Y., Sandhu, A. T., Sweitzer, N. K., Warraich, H. J., Butler, J., Hsich, E., Pressler, S. B., Shah, K., Taylor, K., Sabe, M., Ng, T., & Chair, H. S. S. (2022). Economic issues in Heart failure in the United States. Journal of Cardiac Failure, 28(3), 453–466. https://doi.org/10.1016/j.cardfail.2021.12.017. C. M.
Shafie, A. A., Tan, Y. P., & Ng, C. H. (2017). Systematic review of economic burden of heart failure. Heart Failure Reviews, 23(1), 131–145. https://doi.org/10.1007/s10741-017-9661-0
Johansson, I., Joseph, P., Balasubramanian, K., et al. (2021). Health-Related Quality of Life and Mortality in Heart failure: The Global Congestive Heart failure study of 23 000 patients from 40 countries. Circulation, 143(22), 2129–2142. https://doi.org/10.1161/CIRCULATIONAHA.120.050850
Article CAS PubMed Google Scholar
Sepehrvand, N. S., Spertus, A., Dyck, J. A., Anderson, J. R. B., & Howlett, T.,Jonathan (2020). Change of Health-Related Quality of Life over Time and its Association with patient outcomes in patients with heart failure. Journal of the American Heart Association, 9(17), e017278. https://doi.org/10.1161/JAHA.120.017278
Tromp, J., Bamadhaj, S., Cleland, J. G. F., Angermann, C. E., Dahlstrom, U., Ouwerkerk, W., Tay, W. T., Dickstein, K., Ertl, G., Hassanein, M., Perrone, S. V., Ghadanfar, M., Schweizer, A., Obergfell, A., Lam, C. S. P., Filippatos, G., & Collins, S. P. (2020). Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): A cohort study. The Lancet Global Health, 8(3), e411–e422. https://doi.org/10.1016/S2214-109X(20)30004-8
Whellan, D., McCarey, M. M., Chen, H., Nelson, M. B., Pastva, A. M., Duncan, P., Mentz, R. J., Kitzman, D. W., Reeves, G., & Reed, S. D. (2022). Quality of Life Trajectory and its mediators in older patients with Acute Decompensated Heart failure receiving a Multi-domain Rehabilitation intervention: Results from the Rehabilitation Therapy in older Acute Heart failure patients trial. Circulation. Heart Failure, 15(12), e009695. https://doi.org/10.1161/circheartfailure.122.009695
Article CAS PubMed Google Scholar
Warraich, H. J., Kitzman, D. W., Whellan, D. J., Duncan, P. W., Mentz, R. J., Pastva, A. M., Nelson, M. B., Upadhya, B., & Reeves, G. R. (2018). Physical function, Frailty, Cognition, Depression, and quality of life in hospitalized adults ≥ 60 years with Acute Decompensated Heart failure with preserved Versus reduced ejection fraction. Circ, 11(11), e005254. https://doi.org/10.1161/CIRCHEARTFAILURE.118.005254
Vaduganathan, M., Claggett, B. L., McMurray, J. J. V., & Solomon, S. D. (2022). Health Status trajectories before and after hospitalization for heart failure. Circulation, 145(25), 1872–1874. https://doi.org/10.1161/CIRCULATIONAHA.122.059282
Garcia-Soleto, A., Parraza-Diez, N., Aizpuru-Barandiaran, F., Aros-Borau, F., Zuazu, H., Martin-Gudino, M., & Cobos, J. (2013). Comparative study of quality of life after hospital-at-home or in-patient admission for acute decompensation of chronic heart failure. World Journal of Cardiovascular Diseases, 3, 174–181. https://doi.org/10.4236/wjcd.2013.31A025
Hand, C. (2016). Measuring health-related quality of life in adults with chronic conditions in primary care settings: Critical review of concepts and 3 tools. Canadian Family Physician, 62(7), e375–383.
Shah, K. P., Khan, S. S., Baldridge, A. S., Grady, K. L., Cella, D., Goyal, P., Allen, L. A., Smith, J. D., Lagu, T. C., & Ahmad, F. S. (2024). Health Status in Heart failure and Cancer: Analysis of the Medicare Health outcomes Survey 2016–2020. JACC: Heart Failure, 12(7), 1166–1178. https://doi.org/10.1016/j.jchf.2023.10.003
Article CAS PubMed Google Scholar
Comín-Colet, J., Anguita, M., Formiga, F., Almenar, L., Crespo-Leiro, M. G., Manzano, L., Muñiz, J., Chaves, J., de Frutos, T., & Enjuanes, C. (2016). Health-related quality of life of patients with chronic systolic heart failure in Spain: Results of the VIDA-IC study. Revista Española De Cardiología (English Edition), 69(3), 256–271. https://doi.org/10.1016/j.rec.2015.07.030
Kraai, I. H., Vermeulen, K. M., Luttik, M. L. A., Hoekstra, T., Jaarsma, T., & Hillege, H. L. (2013). Preferences of heart failure patients in daily clinical practice: Quality of life or longevity? European Journal of Heart Failure, 15(10), 1113–1121. https://doi.org/10.1093/eurjhf/hft071
Wolowacz, S. E., Briggs, A., Belozeroff, V., Clarke, P., Doward, L., Goeree, R., Lloyd, A., & Norman, R. (2016). Estimating Health-State Utility for Economic Models in Clinical studies: An ISPOR Good Research practices Task Force Report. Value in Health, 19(6), 704–719. https://doi.org/10.1016/j.jval.2016.06.001
Brazier, J. E., Rowen, D., Lloyd, A., & Karimi, M. (2023). Future directions in valuing benefits for estimating QALYs: Is time up for the EQ-5D? Value in Health, 22(1), 62–68. https://doi.org/10.1016/j.jval.2018.12.001
Gray, A. M. C., Wolstenholme, P. M., & Wordsworth, J. L., S (2011). Applied methods of cost-effectiveness analysis in health care. Oxford University Press.
Brazier, J., Ara, R., & Azzabi, I. (2019). Identification, review, and Use of Health State Utilities in cost-effectiveness models: An ISPOR Good practices for Outcomes Research Task Force Report. Value in Health, 22(3), 267–275. https://doi.org/10.1016/j.jval.2019.01.004
Kuan, W. C., Sim, R., Wong, W. J., Dujaili, J., Kasim, S., Lee, K. K. C., & Teoh, S. L. (2023). Economic evaluations of Guideline-Directed Medical therapies for Heart failure with reduced ejection fraction: A systematic review. Value in Health, S1098-3015(23), 02613–X. https://doi.org/10.1016/j.jval.2023.05.011
Di Tanna, G. L., Chen, S., Bychenkova, A., Wirtz, H., Burrows, K., & Globe, G. (2020). Economic evaluations of pharmacological treatments in heart failure patients: A methodological review with a focus on Key Model drivers. Pharmacoeconomics Open, 4(3), 397–401. https://doi.org/10.1007/s41669-019-00173-y
Gemma, E. S., Adrian, W., Patrick, D., Anthony, H., Deborah, B., & Linda, M. D. (2018). Cost-effectiveness of cardiac rehabilitation: A systematic review. Heart, 104(17), 1403. https://doi.org/10.1136/heartjnl-2017-312809
Elm, E., Altman, D. G., Egger, M., Pocock, S. J., & Gøtzsche, P. C.,P, V. J (2007). Strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. British Medical Journal, 335, 806. https://doi.org/10.1136/bmj.39335.541782.AD
Kuan, W. C., Chee, K. H., Kasim, S., Lim, K. K., Dujaili, J. A., Lee, K. K. C., & Teoh, S. L. (2024). Validity and measurement equivalence of EQ-5D-5L questionnaire among heart failure patients in Malaysia: A cohort study. Journal of Medical Economics, 1–16. https://doi.org/10.1080/13696998.2024.2337563
Austin, P. C., & Steyerberg, E. W. (2015). The number of subjects per variable required in linear regression analyses. Journal of Clinical Epidemiology, 68(6), 627–636. https://doi.org/10.1016/j.jclinepi.2014.12.014
Jager, J., Putnick, D. L., & Bornstein, M. H. (2017). More than just convenient: The scientific merits of homogeneous convenience samples. Monographs of the Society for Research in Child Development, 82(2), 13–30. https://doi.org/10.1111/mono.12296
Shafie, A. A., Thakumar, V., Lim, A., Luo, C. J., Rand-Hendriksen, N., K., & Yusof, M., F. A (2019). EQ-5D-5L valuation for the Malaysian Population. Pharmacoeconomics, 37(5). https://doi.org/10.1007/s40273-018-0758-7
Simons, C. L., Rivero-Arias, O., Yu, L. M., & Simon, J. (2014). Multiple imputation to deal with missing EQ-5D-3L data: Should we impute individual domains or the actual index? Quality of Life Research, 24(4), 805–815. https://doi.org/10.1007/s11136-014-0837-y
Rösel, I., Serna-Higuita, L., Al Sayah, F., Buchholz, M., Buchholz, I., Kohlmann, T., P, M., & Feng, Y. (2022). What difference does multiple imputation make in longitudinal modeling of EQ-5D-5L data? Empirical analyses of simulated and observed missing data patterns. Quality of Life Research, 31(5), 1521–1532. https://doi.org/10.1007/s11136-021-03037-3
Pharmacoeconomics, 41(12). https://doi.org/10.1007/s40273-023-01297-0.
Boczor, S., Eisele, M., Rakebrandt, A., Menzel, A., Blozik, E., Träder, J. M., Störk, S., Herrmann-Lingen, C., & Scherer, M. (2021). Prognostic factors associated with quality of life in heart failure patients considering the use of the generic EQ-5D-5L™ in primary care: New follow-up results of the observational RECODE-HF study. BMC Family Practice, 22(1), 1–11. https://doi.org/10.1186/s12875-021-01554-1
Alva, M., Gray, A., Mihaylova, B., & Clarke, P. (2014). The effect of diabetes complications on health-related quality of life: The importance of longitudinal data to address patient heterogeneity. Health Economics, 23(4). https://doi.org/10.1002/hec.2930
Moore, J. F., & Weatherford, L. R. Decision Modeling with Microsoft Excel (6th ed.). Pearson.
Hay, J. W., Gong, C. L., Jiao, X., Zawadzki, N. K., Zawadzki, R. S., Pickard, A. S., Xie, F., Crawford, S. A., & Gu, N. Y. (2021). A US Population Health Survey on the impact of COVID-19 using the EQ-5D-5L. Journal of General Internal Medicine, 36(5), 1292–1301. https://doi.org/10.1007/s11606-021-06674-z
Article PubMed PubMed Central Google Scholar
Luke, S. G. (2017). Evaluating significance in linear mixed-effects models in R. Behavior Research Methods, 49(4), 1494–1502. https://doi.org/10.3758/s13428-016-0809-y
Comments (0)